Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?
about
A Review of the Mechanisms of Blood-Brain Barrier Permeability by Tissue-Type Plasminogen Activator Treatment for Cerebral IschemiaPhysiological and pathological roles of tissue plasminogen activator and its inhibitor neuroserpin in the nervous systemSelective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin.The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.Platelet-Derived Growth Factor Receptor-β Regulates Vascular Smooth Muscle Cell Phenotypic Transformation and Neuroinflammation After Intracerebral Hemorrhage in Mice.Astrocytes regulate the balance between plasminogen activation and plasmin clearance via cell-surface actin.Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in miceA Simple Adaptable Blood-Brain Barrier Cell Model for Screening Matrix Metalloproteinase Inhibitor Functionality.2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: Thrombotic Stroke: Neuroprotective Therapy by Recombinant-Activated Protein C.Role of PDGF-D and PDGFR-β in neuroinflammation in experimental ICH mice model.Activities of wild-type and variant tissue-type plasminogen activators retained on vascular endothelial cells.Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa.Physiologic variations in blood plasminogen levels affect outcomes after acute cerebral thromboembolism in mice: a pathophysiologic role for microvascular thrombosis.Editorial: The Role of the Plasminogen Activating System in Neurobiology.Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH.Worse Outcome in Stroke Patients Treated with rt-PA Without Early Reperfusion: Associated Factors.Reperfusion facilitates reversible disruption of the human blood-brain barrier following acute ischaemic stroke.Fibrinolysis: from blood to the brain.Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse.Regulation of Dipeptidyl Peptidase IV in the Post-stroke Rat Brain and In Vitro Ischemia: Implications for Chemokine-Mediated Neural Progenitor Cell Migration and Angiogenesis.Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes.Severe Blood-Brain Barrier Disruption in Cardioembolic Stroke.SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells.Early Abrogation of Gelatinase Activity Extends the Time Window for tPA Thrombolysis after Embolic Focal Cerebral Ischemia in Mice.Impact of Bradykinin Generation During Thrombolysis in Ischemic Stroke
P2860
Q26772837-B572ED95-9EB0-443F-BDDA-8A0CDDE43F48Q26777276-BAB7DB67-8D60-4628-8921-DD1AB9F65FC4Q33693655-2FC13263-BD4E-4FEF-93A3-CC4196C91A36Q36079853-E2DEA971-DB21-4C36-A027-5C1C3B0E50B3Q36905476-08FF9F9A-1CAF-43EF-A219-DF65205CFD02Q37654707-9CED1E9E-121F-4174-A6AF-6499DBE251CCQ38848525-82A5F113-90C4-453A-839E-06D2870B5210Q38904212-A03B607B-AEBE-4297-B378-18FBBF95EECEQ38985138-1EEB5A90-67DB-458B-A02F-FB4ADF29942AQ39621498-1985B2F6-45A4-46D3-81EC-42D947CAE3E1Q40988590-EE50C8F1-00C5-489A-B656-FAB8CE0AD85EQ41102431-33DE365A-7E37-4F7C-8236-FDC6596977C1Q41174665-90A46CF0-8D05-4235-8036-B9928820BCECQ42388151-46092BA9-8D24-4D6E-B902-B37FA94EFDFBQ42427291-5923B85E-D50E-4D17-82EF-66C5BBAA35C4Q47101474-3F470C69-DB64-49FA-B586-EADCF9BCC36CQ47223299-F000365D-DE3F-43F9-9471-A303AE23409BQ47655114-11A8E2EC-3943-46BC-A6B4-AE234BF2C0BAQ48106697-2AB3895B-6106-4D26-92C6-68C5201CBF5CQ48487114-99043485-E604-45AC-975A-08CA3D850742Q48570285-0C61EA19-E08D-4893-BD8D-37264493EE01Q49197963-1026C352-E6D9-449D-A42A-73AA62506778Q50280905-9A6A3E09-0995-4F9B-B69E-FAF408864C24Q55116313-F5750A4A-3451-4BB3-BC73-4DC98BD69D73Q55365943-68F3D0E8-54A8-4656-9FEF-5144C3427F00Q58179635-D7C9A4F0-370A-4589-9B21-2E371D6B51D7
P2860
Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Plasmin-dependent modulation o ...... ring tPA-induced thrombolysis?
@ast
Plasmin-dependent modulation o ...... ring tPA-induced thrombolysis?
@en
Plasmin-dependent modulation o ...... ring tPA-induced thrombolysis?
@nl
type
label
Plasmin-dependent modulation o ...... ring tPA-induced thrombolysis?
@ast
Plasmin-dependent modulation o ...... ring tPA-induced thrombolysis?
@en
Plasmin-dependent modulation o ...... ring tPA-induced thrombolysis?
@nl
prefLabel
Plasmin-dependent modulation o ...... ring tPA-induced thrombolysis?
@ast
Plasmin-dependent modulation o ...... ring tPA-induced thrombolysis?
@en
Plasmin-dependent modulation o ...... ring tPA-induced thrombolysis?
@nl
P2860
P356
P1476
Plasmin-dependent modulation o ...... ring tPA-induced thrombolysis?
@en
P2093
Be'eri Niego
Robert L Medcalf
P2860
P304
P356
10.1038/JCBFM.2014.99
P577
2014-06-04T00:00:00Z